The Latest Cardiac and Vascular News
International gathering of more than 1,400 vascular specialists will feature the latest data on limb-threatening diseases, novel technology and integration of specialty within larger healthcare system BOSTON, MA, MAY 27, 2026 – The Society for Vascular Surgery’s Vascular Annual Meeting (VAM) will commence on Wednesday, June 10, 2026, uniting the greatest […]
PROVIDENCE, R.I., May 27, 2026 /PRNewswire/ — In a new feasibility study published in Annals of Family Medicine, general practitioners (GPs) in China were able to accurately detect carotid artery plaque — an indicator of cardiovascular disease — in high-risk patients using an AI-assisted…
MENLO PARK, Calif.–(BUSINESS WIRE)– #TFX–Jupiter Endovascular announced positive results from its SPIRARE II pivotal trial at EuroPCR showing the trial met both of its primary endpoints.
Study evaluates whether Amplifi therapy enables AVF maturation at two weeks, potentially reducing catheter dependence and transforming the dialysis access pathway BOSTON, May 19, 2026 /PRNewswire/ — Amplifi Vascular, a clinical-stage medical technology company developing the Amplifi™…
SANTA ROSA, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™ Thrombectomy System from Surmodics, Inc. The transaction closed on May 18, 2026. The Pounce System is an FDA-cleared, fully mechanical thrombectomy system for the non-surgical removal of thrombi and emboli from peripheral arteries. Built around proprietary
Newly issued patents in Australia and Japan cover the company’s Artero™ E-IVL and Sola™ L-IVL platforms as FastWave advances toward peripheral and coronary IDE trials. MINNEAPOLIS, May 19, 2026 /PRNewswire/ — FastWave Medical has added four international patents to its intellectual…
WASHINGTON, May 14, 2026 /PRNewswire/ — DeepQure, a clinical-stage medical device company, announced the completion of its featured presentation at the American Urological Association (AUA) Innovation Nexus Forum, held during the AUA Annual Meeting. DeepQure was selected to present the…
DALLAS, TX, UNITED STATES, May 5, 2026 /EINPresswire.com/ — Solaris Endovascular, Inc, a medical device company focused on next-generation endovascular therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its first-in-class Solaris DE™ drug-eluting covered stent indicated for use in hemodialysis patients for […]
— Coils minimize CT/MRI artifacts, remain radiopaque under fluoroscopy — BOULDER, Colo., May 6, 2026 /PRNewswire/ — Embolization, Inc., will present its novel vascular embolization device, using proprietary shape-memory biocompatible polymers, at the Annual GEST Conference, Booth No….
Microbot Medical®’s LIBERTY® System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
